BWS Financial maintains Sell rating on Twist Bioscience
BWS Financial maintained a Sell rating on Twist Bioscience, with a $45.00/share price target, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
BWS Financial maintains Sell rating on Twist Bioscience
BWS Financial maintained a Sell rating on Twist Bioscience and reiterated a $45.00 price target, implying 71.1% downside versus the Sep 17 close of $155.56.